entertainment -WSS

entertainment

author：knowledge 2025-09-30 12:11:01 - browse：37

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： What to expect as Trump is arraigned on his Jan 6. indictment

explore

WSS

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Sage hopes for a blockbuster in antidepressant now before FDA

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Radiation, mainstay of cancer treatment, begins a fade

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Australia’s approach to dialysis celebrates life

hotspot

entertainment

hotspot

Peter Hotez and the public health issue of online harassment

As pharma fights Medicare drug negotiation, hospitals, docs silent

Virginia high school admissions case could be legal follow

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What the US credit downgrade means for the economy, your finances

Moonlake's readout produced a cash windfall. Risks remain

Trump indictment: Who are the 'co

Walensky prepares to leave CDC — and Congress — behind

Infectious disease expert Jeanne Marrazzo assumes Fauci role

focus

No plane should take off without an EpiPen onboard

Amazon expands telehealth clinic nationwide

How Long Island became the ‘eugenics capital of the world’

Appeals court upholds limits to abortion pill

FDA panel gives mixed vote on blood pressure devices

Complete sequence of Y chromosome published for first time

explore

hotspot

explore

hotspot